15.02.2018 • News

Lanxess Completes Solvay Additives Buy

German specialty chemicals producer Lanxess has successfully completed its...
German specialty chemicals producer Lanxess has successfully completed its acquisition of Solvay’s €65 million phosphorus chemicals business, including the Belgian group’s US production site at Charleston, South Carolina (c) Lanxess

Following the approval of all regulatory instances, German specialty chemicals producer Lanxess has successfully completed its acquisition of Solvay’s €65 million phosphorus chemicals business, including the Belgian group’s US production site at Charleston, South Carolina.

The business’s transfer was agreed in November 2017.

Solvay’s Charleston site includes six production plants, in which roughly 90 employees manufacture phosphorus chloride and derivatives such as flame-retardant additives and agricultural intermediates.

Lanxess said the acquisition fully complements its strategy to grow its business in mid-sized markets and in the regions North America and Asia.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read